KAMDA Conference
2026 KAMDA Conference
The 2nd KAMDA Conference is on December 2, 2026 at SK Biopharm in Paramus, NJ. Registration is open. It is free, and you don't need to be a member to attend.
October 23, 2025 · Reed Smith LLP, 22nd Floor, 599 Lexington Ave, New York, NY 10022
The 1st KAMDA Conference
“Facing the Real Barriers: Korean Medical Device Companies' Strategic Entry into the U.S.”
Who it was for
- Korean-American medical device industry professionals
- Healthcare providers
- FDA, insurance and legal experts
- Investors and related stakeholders
Program highlights
- Expert session on U.S. FDA regulations
- Insurance and reimbursement system overview
- Sponsor presentations
- Panel discussion: strategic entry into the U.S. market
- Networking dinner and pre-event meetings
Program, October 23, 2025
Download the 2025 program| Time | Session | Speaker | Affiliation |
|---|---|---|---|
| 9:30 to 10:30 AM | Registration & Networking | ||
| 10:30 to 11:00 AM | Welcome Remark | HeaYeon Lee, Ph.D. | CEO, MARA Nanotech; Vice President, KAMDA |
| Congratulatory Remark | SeongSoo Kim | Consulate General of the Republic of Korea, New York | |
| Congratulatory Remark | SoonMahn Park | Head of Korea Health Industry Development Institute, Boston Office | |
| Congratulatory Remark | SungWoo Baek | Director, New York Global Business Center, Korea SMEs & Startups Agency | |
| Congratulatory Remark | MyeongSeon Kim | Director, Korea Venture Investment Corp., New York office | |
| 11:00 to 11:20 AM | Opening Plenary: Technology Trends and Market Status of Biosensors in U.S. | HeaYeon Lee, Ph.D. | CEO, MARA Nanotech; Conference Chair, KAMDA |
| 11:20 AM to 12:00 PM | Keynote: Significance of KAMDA Establishment & Success Case in the U.S. Market (AccessBio) | YoungHo Choi | Chairman, Access Bio; Co-Chair, KAMDA |
| 12:00 to 1:00 PM | Lunch | ||
| 1:00 to 1:40 PM | Special Session I: FDA Trends & Global Regulation Insights | Haja Sittana El Mubarak, Ph.D. | Wasela Diagnostics LLC |
| 1:40 to 2:00 PM | FDA Approval Strategies and Success Cases | ByungSik Chang, Ph.D. | CEO, Nano-Ditech; Co-Chair, KAMDA |
| 2:00 to 2:20 PM | FDA Preparation and Approval Strategy (CRO) | JungYoup Han, Ph.D. | CSO, Target Health; Treasurer, KAMDA |
| 2:20 to 2:40 PM | Appropriate Risk Allocation in the FDA World | Sung Park | Reed Smith |
| 2:40 to 2:50 PM | Coffee break | ||
| 2:50 to 3:30 PM | Special Session II: Understanding the U.S. Healthcare Insurance System (Reimbursement system) | MinSoo Seo | CEO, Taewoong Medical USA |
| 3:30 to 3:50 PM | Market Entry Strategy for the U.S. (Applications of LDT and CLIA Lab) | JungHee Cho, Ph.D. | CEO, LabG USA; Executive Secretary, KAMDA |
| 3:50 to 4:10 PM | Market Entry Strategy for the U.S. (Case Studies of U.S. Local Company Acquisitions) | Curie Choi | Director, Immunostics; Operations Committee, KAMDA |
| 4:10 to 4:30 PM | Understanding IP and Compliance | Eunjean Je | Morgan, Lewis & Bockius LLP |
| 4:30 to 5:15 PM | Sponsored Session | ||
| 5:15 to 5:30 PM | Coffee break | ||
| 5:30 to 6:30 PM | Panel: U.S. Market Entry and Medical Device Market Strategy | Moderator: HeaYeon Lee, Ph.D. | Panel: MinSoo Seo, YoungHo Choi, ByungSik Chang, JungHee Cho, JungYoup Han |
| 6:30 to 6:40 PM | Closing ceremony | ||
| 6:40 to 8:30 PM | Dinner & Networking |
Program as published by KAMDA in September 2025.